P1105: FINAL RESULTS OF THE PHASE I/II HOVON124/ECWM-R2 STUDY INCLUDING 2-YEAR RITUXIMAB MAINTENANCE AFTER INDUCTION WITH IXAZOMIB, RITUXIMAB AND DEXAMETHASONE IN RELAPSED WALDENSTRÖM’S MACROGLOBULINEMIA

P1105: FINAL RESULTS OF THE PHASE I/II HOVON124/ECWM-R2 STUDY INCLUDING 2-YEAR RITUXIMAB MAINTENANCE AFTER INDUCTION WITH IXAZOMIB, RITUXIMAB AND DEXAMETHASONE IN RELAPSED WALDENSTRÖM’S MACROGLOBULINEMIA

Bibliographic Details
Main Authors:	M.-A. Dimopoulos, K. Amaador, M. C. Minnema, K. Nasserinejad, M. Kap, E. Kastritis, M. Gavriatopoulou, W. Kraan, M. E. D. Chamuleau, D. Deeren, L. Tick, J. K. Doorduijn, F. Offner, L. H. Böhmer, R. D. Liu, S. T. Pals, J. M. Vos, M. J. Kersten
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000847288.62394.e8

Similar Items

P1176: RITUXIMAB IN PRIMARY CNS LYMPHOMA – LONG TERM FOLLOW-UP OF THE PHASE III HOVON 105/ALLG NHL 24 STUDY
by: J. Doorduijn, et al.
Published: (2022-06-01)

A Promising New Therapy of Oral Ixazomib Without Rituximab for Waldenstrom Macroglobulinemia
by: Wanlu Ma, et al.
Published: (2021-02-01)

HOVON110/ReBeL Study: Results of the Phase I Part of a Randomized Phase I/II Study of Lenalidomide, Rituximab With or Without Bendamustine in Patients With Relapsed/Refractory Follicular Lymphoma
by: Wendy B.C. Stevens, et al.
Published: (2020-02-01)

P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY
by: K. Groen, et al.
Published: (2023-05-01)

P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS OF THE MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY
by: K. Groen, et al.
Published: (2022-06-01)

P905: IXAZOMIB-THALIDOMIDE-DEXAMETHASONE INDUCTION FOLLOWED BY IXAZOMIB OR PLACEBO MAINTENANCE IN NON-TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS; LONG-TERM RESULTS OF HOVON-126/NMSG 21.13
by: K. Groen, et al.
Published: (2022-06-01)

The Role of Rituximab in the Treatment of Primary Central Nervous System Lymphoma
by: Ruben Van Dijck, et al.
Published: (2021-04-01)

Rituximab Iodination Procedure for Radioiodinated Rituximab (131I-Rituximab) Preparation
by: Martalena Ramli, et al.
Published: (2019-06-01)

Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13
by: Kazimierz Groen, et al.
Published: (2023-09-01)

P877: IXAZOMIB DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY
by: Kaz Groen, et al.
Published: (2023-08-01)

Rituximab: historia, farmacología y perspectivas Rituximab: history, pharmacology and perspectives
by: Edgardo E. Espinosa Estrada, et al.
Published: (2010-12-01)

RITUXIMAB IN PEDIATRIC RHEUMATOLOGY
by: E.I. Alexeeva, et al.
Published: (2010-01-01)

RITUXIMAB IN PEDIATRIC RHEUMATOLOGY
by: E.I. Alexeeva, et al.
Published: (2010-05-01)

Safety of rituximab in rheumatoid arthritis
by: F. Atzeni, et al.
Published: (2011-06-01)

Rituximab therapy in Greek patients with rheumatoid arthritis
by: Haralampos M Moutsopoulos, et al.
Published: (2008-10-01)

P899: HOVON 104; LONG TERM FOLLOW-UP OF AUTOLOGOUS STEM CELL TRANSPLANTATION AFTER BORTEZOMIB INDUCTION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED AL AMYLOIDOSIS
by: Monique Minnema, et al.
Published: (2023-08-01)

POS-455 RITUXIMAB IN MANAGEMENT OF PEDIATRIC NEPHROTIC SYNDROME
by: M. KUNTHARA, et al.
Published: (2021-04-01)

Marked deterioration in rheumatoid arthritis associated bronchiectasis following treatment with Rituximab
by: K. Musameh, et al.
Published: (2019-01-01)

BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis.
by: Bukhari, M, et al.
Published: (2011)

Rituximab Monotherapy versus Rituximab and Bortezomib Combination Therapy for Treatment of Non-paraneoplastic Autoimmune Retinopathy
by: Arash Maleki, et al.
Published: (2022-11-01)

Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab
by: Sonia Boyer-Suavet, et al.
Published: (2020-01-01)

Use of rituximab in pediatric nephrology practice
by: Ye.K. Lagodych
Published: (2023-03-01)

Rituximab Dosing in Glomerular Diseases: A Scoping Review
by: Husam Alzayer, et al.
Published: (2022-10-01)

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.
by: Jones, R, et al.
Published: (2010)

Lupus Nephritis: Experience of Treatment with Rituximab (Clinical Observation)
by: D.D. Ivanov, et al.
Published: (2012-05-01)

Rituximab-Related Reversible Hepatocellular Damage
by: Selami K. Toprak, et al.
Published: (2012-12-01)

Commentary: Rituximab in scleritis
by: Parthopratim Dutta Majumder
Published: (2020-01-01)

Use of rituximab in glomerulopathies
by: Cristiane Bitencourt Dias, et al.
Published: (2022-02-01)

The Role of Rituximab in Lymphomas
by: Bertrand Coiffier
Published: (2002-01-01)

PREDICTION OF TOCILIZUMAB AND RITUXIMAB EFFECTIVENESS IN RHEUMATOID ARTHRITIS
by: Volkava M. V.
Published: (2019-11-01)

Development of anti-rituximab antibodies in rituximab-treated patients: Related parameters & consequences
by: Fatemeh Saffari, et al.
Published: (2022-01-01)

Rituximabe na síndrome de Felty refratária Rituximab in the refractory Felty's syndrome
by: Thiago Sotero Fragoso, et al.
Published: (2009-04-01)

Macroglobulinemia de Waldenström - remissão completa após tratamento com rituximabe Successful outcome in Waldenström's macroglobulinemia treated with rituximab
by: Flavia C. F. Pimenta, et al.
Published: (2008-10-01)

EXPERIENCE OF TREATMENT WITH RITUXIMAB IN PATIENT WITH JUVENILE POLYARTERITIS
by: E.I. Alexeeva, et al.
Published: (2011-03-01)

EXPERIENCE OF TREATMENT WITH RITUXIMAB IN PATIENT WITH JUVENILE POLYARTERITIS
by: E.I. Alexeeva, et al.
Published: (2011-01-01)

The role of rituximab in the treatment of myasthenia gravis
by: Benveniste, O, et al.
Published: (2010)

Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease
by: Joanna Tieu, et al.
Published: (2021-05-01)

Livedoid vasculopathy: experience in using rituximab
by: Tatyana Valentinovna Beketova, et al.
Published: (2011-08-01)

USE OF RITUXIMAB IN PATIENTS WITH LUPUS NEPHRITIS
by: Anna Vasilyevna Torgashina, et al.
Published: (2010-08-01)

Rituximab for the treatment of patients with chronic lymphocytic leukemia
by: M Gentile, et al.
Published: (2010-03-01)